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Lentiviruses have evolved to acquire an auxiliary protein Vpx to counteract the intrinsic host
restriction factor SAMHD1. Although Vpx is phosphorylated, it remains unclear whether such
phosphorylation indeed regulates its activity toward SAMHD1. Here we identify the PIM
family of serine/threonine protein kinases as the factors responsible for the phosphorylation
of Vpx and the promotion of Vpx-mediated SAMHD1 counteraction. Integrated proteomics
and subsequent functional analysis reveal that PIM family kinases, PIM1 and PIM3, phos-
phorylate HIV-2 Vpx at Ser13 and stabilize the interaction of Vpx with SAMHD1 thereby
promoting ubiquitin-mediated proteolysis of SAMHD1. Inhibition of the PIM kinases pro-
motes the antiviral activity of SAMHD1, ultimately reducing viral replication. Our results
highlight a new mode of virus–host cell interaction in which host PIM kinases facilitate
promotion of viral infectivity by counteracting the host antiviral system, and suggest a novel
therapeutic strategy involving restoration of SAMHD1-mediated antiviral response.
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Reciprocal interplay between virus and host proteins playsimportant roles in both promoting and suppressing viralreplication1,2. Several host proteins exert significant anti-
viral effects at multiple steps of the viral life cycle, but viruses
have evolved to counteract such host defenses and achieve effi-
cient replication3. Moreover, by hijacking host cell machinery,
viruses take advantage of cellular regulatory systems to promote
successful progeny production and spread.
Sterile alpha motif and histidine-aspartate domain-containing
protein 1 (SAMHD1) was identified as an inhibitor of several
lentiviruses, including human immunodeficiency virus (HIV).
SAMHD1 acts as a deoxynucleotide triphosphate (dNTP) phos-
phohydrolase4, and thus lowers the concentration of dNTPs
required for viral reverse transcription in infected non-dividing
myeloid cells and resting T cells5,6. On the other hand, viruses can
overcome SAMHD1-mediated viral restriction through utilizing
viral protein X (Vpx), an accessory protein encoded by human
immunodeficiency virus type 2 (HIV-2) and some strains of
simian immunodeficiency virus (SIV)7,8. In fact, Vpx hijacks a
Cullin-RING ubiquitin ligase (CRL) complex that associates
with the host E3 ubiquitin ligase components, i.e., DCAF1,
DDB1, and CUL4, to promote the ubiquitin-mediated proteolysis
of SAMHD19. These events, by suppressing the host innate
immune system, ultimately result in efficient viral replication.
Host protein kinases directly phosphorylate viral proteins
during infection and control the efficiency of viral replication. In
HIV infection, the human protein kinases ERK210 and atypical
PKC11 phosphorylate the HIV-1 Gag protein to regulate viral
assembly, release, and infectivity. Moreover, phosphorylation of
the HIV-1 capsid by maternal embryonic leucine zipper kinase
(MELK) promotes viral uncoating and cDNA synthesis12. Pre-
vious reports demonstrated that Vpx is also phosphorylated
during infection13–15. Although phosphorylation of Vpx seems to
influence its nuclear import or packaging into virions14, it
remains uncertain whether Vpx phosphorylation contributes to
its crucial function in the degradation of SAMHD1. Moreover, it
is not clear which host kinases are responsible for the functional
phosphorylation of Vpx.
In this study, we perform a comprehensive proteomic analysis
for the molecular interactions between human protein kinases
and HIV-2 Vpx, and identify PIM kinases as regulatory factors
for Vpx-mediated SAMHD1 degradation. Our findings thus
reveal a regulatory mechanism of virus–host interaction that
governs viral escape from an intrinsic cellular immune defense via
the post-translational modification of viral protein.
Results
Identification of host kinases that phosphorylate Vpx. To
comprehensively survey host kinase(s) that might bind to HIV-2
Vpx and influence its function, we performed an in vitro
protein–protein interaction screen using the amplified lumines-
cent proximity homogenous assay (AlphaScreen). Full-length
Vpx and 412 human protein kinases were separately synthesized
using the wheat cell-free protein production system, and each
kinase was screened for interaction with Vpx (Supplementary
Fig. 1). When a relative light unit per cutoff (RLU/Co) ratio of
≥1.5 was set as the threshold, 50 host kinases were identified as
potentially interacting with Vpx in vitro (Fig. 1a). To search for
biologically significant kinases, we next performed a cell-based
interaction analysis using the recently developed NanoLuc bio-
luminescence resonance energy transfer (NanoBRET) assay
(Supplementary Fig. 2). Among the 50 candidates selected in the
first screening, we identified three host kinases, namely, PIM1,
PIM3, and PDK1 (Fig. 1b), that interacted intimately with Vpx in
living cells, as revealed by the fact that these kinases yielded the
highest BRET signal (RLU/Co ratio of ≥20). Since two of these
proteins, PIM1 and PIM3, are members of PIM (Proviral
Integration site for Moloney murine leukemia virus) family of
kinases, we decided to focus on PIM kinase family. An immu-
noprecipitation analysis further revealed that PIM1 and PIM3,
but not another PIM kinase family member, PIM2, stably inter-
acted with Vpx (Fig. 1c). To functionally analyze the PIM family
kinases in relation to Vpx, we investigated whether the PIM
kinases could directly phosphorylate Vpx in vitro. To this end,
biotinylated Vpx was incubated with recombinant kinases, and
this mixture was then processed for an in vitro kinase assay using
radioactive adenosine 5′-triphosphates. The result revealed that
phosphorylation of Vpx could be performed by PIM3, and to a
lesser extent by PIM1, while PIM2 phosphorylated much less Vpx
protein than PIM1 and PIM3 in vitro (Fig. 1d). We also detected
Vpx phosphorylation by FYN kinase, as reported previously15
(Fig. 1d). Together, these results indicate that the PIM family
kinases, namely, PIM1 and PIM3, are previously uncharacterized
host mediators of Vpx phosphorylation.
PIM kinases phosphorylate the Ser13 residue of Vpx. To
determine the sites on Vpx phosphorylated by PIM kinases, we
performed a proteomic analysis. For these experiments, cells were
transfected with Vpx with or without PIM3, and immunopreci-
pitated Vpx was subjected to liquid chromatography tandem-
mass spectrometry analysis. Subsequent in-depth data analysis
revealed that PIM3 could phosphorylate three amino acid resi-
dues (Ser13, Thr88, and Ser101) of Vpx (Fig. 2a, b and Supple-
mentary Fig. 3). Multiple sequence alignment revealed that the
amino acid sequence N-terminal to the Ser13 phospho-acceptor
site is highly conserved (98.7%) among HIV-2 and SIV isolates
(SIVmac and SIVsmm) (Fig. 2c). To further investigate the roles
of PIM kinases in Vpx function, we created a phospho-specific
antibody that specifically recognizes site-specific phosphorylation
of Vpx Ser13. Using this antibody, we confirmed that PIM1 and
PIM3, but not PIM2, could phosphorylate Vpx Ser13 in vitro
(Fig. 2d). Ectopic expression of wild-type PIM3, but not its
kinase-dead mutant (K69M)16, significantly enhanced the phos-
phorylation of Vpx Ser13 in cells (Fig. 2e). We confirmed that this
phosphorylation was detected in wild-type Vpx, but not its S13A
mutant (Supplementary Fig. 4a). Moreover, we found that
another candidate, PDK1, selected by initial screening, failed to
phosphorylate this site of Vpx (Supplementary Fig. 4b). Inter-
estingly, PIM3 could phosphorylate SIVmac Vpx (Fig. 2f), sug-
gesting that the PIM kinase-mediated Vpx phosphorylation at
Ser13 is a conserved post-translational modification across the
HIV-2 and SIV lineages.
Low infectivity of HIV-2 bearing Vpx S13A. To investigate the
functional impact of Vpx Ser13 phosphorylation, we next
performed a single-cycle viral infection assay using HIV-2
encoding a luciferase reporter gene (HIV-2-Luc) (Fig. 3a). In
this assay, we used wild-type HIV-2-Luc and viruses encoding
either Vpx-S13A or Vpx-Q76A (lacking the ability to interact
with the CRL4 E3 complex7,17); the Vpx-null (ΔVpx) derivative
was used as a control. The amounts of viral production and Vpx
incorporation into virions were almost equivalent in all of these
viruses (Supplementary Fig. 5). Notably, the infectivity of Vpx-
S13A virus was significantly lower than that of the wild-type
virus in SAMHD1-positive (Monomac6-derived) macrophages
(Fig. 3b). However, this was not the case in SAMHD1-negative
(U937-derived) macrophages (Fig. 3c). Immunoblot analysis
revealed that the levels of SAMHD1 were reduced in macro-
phages infected with wild-type HIV-2, but this reduction was
less prominent in cells infected with the Vpx-S13A virus
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(Fig. 3b). We also found that Vpx-S13A virus exhibited much
lower infectivity than wild-type virus with sustained expression
of SAMHD1, in primary human monocyte–derived macro-
phages (Fig. 3d). We performed parallel experiments using a
virus carrying phosphomimetic Vpx-S13E. Both infectivity and
SAMHD1 degradation of the Vpx-S13E virus were comparable
to those of the wild-type virus (Supplementary Fig. 6),
demonstrating the functional significance of Ser13 phosphor-
ylation. We next performed a multi-cycle HIV-2 replication
analysis using SAMHD1-positive (THP1-derived) macrophages
(Fig. 3e). Consistent with previous reports18, HIV-2 virus
bearing Vpx-Q76A or ΔVpx exhibited significantly lower
replication competency than the wild-type virus in THP1-
derived macrophages (Fig. 3f). In line with the results of single-
cycle infection, HIV-2 carrying Vpx-S13A had lower replication
capacity (Fig. 3f), presumably due to the persistent SAMHD1
expression (Fig. 3g). These results were also confirmed by a flow
cytometry analysis in which infected cells were gated (Supple-
mentary Fig. 7a). Our results revealed that S13A virus exhibited
lower viral infectivity and less potently decreased SAMHD1
levels than the wild-type virus (Supplementary Fig. 7b, c).
Together, these data indicate that the Ser13 residue of Vpx is
functionally significant in SAMHD1 degradation and lentiviral



















































































































































































Fig. 1 Identification of protein kinases responsible for Vpx phosphorylation. a Schematic representation of the AlphaScreen-based luminescent system to
screen for human kinases that interact with HIV-2 Vpx in vitro. Streptavidin-coated donor beads (Do) and anti-FLAG antibody conjugated to protein A
acceptor beads (Ac) were mixed with recombinant Vpx and kinase proteins, respectively, and AlphaScreen signals were detected if the two proteins were
close each other (See Supplementary Fig. 1 for detail procedure). When a relative light unit per cutoff (RLU/Co) ratio of ≥1.5 was set as the threshold, 50
kinases were identified as potentially Vpx-interacting proteins. The AlphaScreen was performed in duplicate for each sample. b NanoBRET-based
secondary screen to identify Vpx-interacting proteins in living cells. HEK293 cells were co-transfected with NanoLuc (NL)-conjugated Vpx and HaloTag
(HT)-fused kinase expression vectors, and then HT-618 ligand and furimazine substrate were added to cells (see Supplementary Fig. 2 for detail
procedure). When a relative BRET signal of ≥20 was set as the threshold, three kinases were identified as Vpx-interacting proteins in living cells. The
NanoBRET was performed in duplicate for each sample. c Immunoprecipitation analysis for PIM family kinases to interact with Vpx. HEK293 cells were
transfected with HA-tagged PIM kinases and FLAG-Vpx. Forty-eight hours after transfection, cells were lysed and then immunoprecipitated with anti-FLAG
antibody followed by immunoblot analysis. d Biochemical approach for detecting the phosphorylation of Vpx by PIM family kinases. Recombinant
biotinylated Vpx and indicated kinase proteins (GST-tagged) were produced in a wheat-germ cell-free system, and then mixed and incubated with 32P-
labeled adenosine 5′-triphosphate. Mixtures were subjected to autoradiography (top) or immunoblotting with anti-GST antibody (middle) or anti-Vpx
(bottom). Dihydrofolate reductase (DHFR) was used as a negative control. Bar graph indicates the percentage of phospho-Vpx in total Vpx, as determined
by densitometry (n= 3, mean ± s.d.). Source data are provided as a Source Data file
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Vpx Ser13 phosphorylation promotes Vpx–SAMHD1 interac-
tion. The Ser13 residue of Vpx was located at the vicinity of the
SAMHD1-binding site, as well as in part of the DCAF1-binding
element (Fig. 4a). To further delineate the molecular mechanism
underlying Ser13 phosphorylation, we performed a molecular
dynamics simulation based on the previously solved structure of the
Vpx–DCAF1–SAMHD1 complex19 to predict phosphorylation-
induced conformational changes. The models constructed in this
study included either unphosphorylated or phosphorylated Vpx,
and revealed that phosphorylation status does not cause an obvious
difference in the structure of Vpx (Fig. 4b). However, our molecular
simulation suggested that the phosphorylation of Vpx Ser13 may
create an additional hydrogen bond with SAMHD1 Ser616, leading
to stabilization of the Vpx–SAMHD1 interaction (Fig. 4c).
To confirm the results of the molecular dynamics simulation,
we investigated the interaction between Vpx and SAMHD1 in
living cells using NanoBRET. We observed a constantly high
BRET signal, reflecting Vpx–SAMHD1 interaction, in the case of
wild-type Vpx, whereas the signal was significantly reduced in the
Vpx-S13A mutant (Fig. 4d). On the other hand, the Vpx-S13A
mutation had no prominent effect on the interaction between
Vpx and DCAF1 (Fig. 4e). These trends were also observed in an
immunoprecipitation analysis in which the Vpx-S13A mutant
bound SAMHD1 to a lesser extent than wild-type Vpx (Fig. 4f±h).
Moreover, Vpx-S13A was less capable of poly-ubiquitinating
SAMHD1 than wild-type Vpx (Fig. 4i). Consistent with this, we
found that Vpx-S13A was less able than wild-type Vpx to degrade
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Fig. 2 PIM kinases directly phosphorylate the Ser13 residue of Vpx. a, b Proteomic analysis revealed potential phospho-acceptor sites within Vpx by PIM3.
HEK293 cells were transfected with plasmid vector encoding Vpx together with either empty vector or PIM3. Immunoprecipitated Vpx was subjected to
liquid chromatography tandem-mass spectrometry. Phosphopeptides of Vpx proteins detected by proteomic analysis in PIM3-expressing HEK293 cells are
described (a). p and c in a sequence indicates phosphorylation and carbamidomethylation, respectively. Typical spectra of S13 phosphopeptides are shown
in b. Representative data of two experiments are shown. c Amino acid sequences around the potential phospho-acceptor sites were alignment of indicated
Vpx of HIV-2/SIV strains. Note that the Ser13 phospho-acceptor site is highly conserved (98.7%). d Detection of in vitro phosphorylation of Vpx by PIM
kinases with phospho-specific antibody. Recombinant Vpx and indicated kinase proteins (His-tagged for PIM1 and GST-tagged for PIM2 and PIM3) were
incubated and subjected to immunoblotting (top) or CBB staining (bottom). e PIM3, but not its kinase-defective mutant, increases Vpx Ser13
phosphorylation. HEK293 cells were co-transfected with expression vectors encoding HA-PIM3 (WT or its kinase-dead mutant K69M) and FLAG-Vpx
derived from HIV-2GL-AN. Forty-eight hours after transfection, cells were harvested and subjected to immunoblot analysis. Bar chart indicates the
percentage of phospho-Vpx in total Vpx as determined by densitometry of immunoblots. f PIM3 phosphorylates SIV-Vpx. HEK293 cells were transfected
with Vpx derived from SIVmac239 and subjected to immunoblot analysis. Bar chart indicates the percentage of phospho-Vpx in total Vpx. All graphs are
presented as a mean ± s.d. (n= 3). **P < 0.01; ***P < 0.001, two-tailed unpaired t-test. Source data are provided as a Source Data file
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Fig. 8a). In addition, we performed a cycloheximide assay to
examine the protein stability of WT and the S13A mutant; the
results revealed that both Vpx proteins had similar protein half-
lives (Supplementary Fig. 8b), indicating that the Ser13
phosphorylation affects its functional activity rather than its
stability. Interestingly, our analysis revealed that SAMHD1-
S616A mutant was resistant to the Vpx-mediated proteolysis
(Supplementary Fig. 9), indicating that Ser616 of SAMHD1 was
indeed responsible for the interaction with Vpx. Together, these
results suggest that phosphorylation of Vpx Ser13 stabilizes the
Vpx–SAMHD1 interaction, thereby promoting ubiquitin-
mediated proteolysis of SAMHD1.
PIM kinase inhibition prevents SAMHD1 degradation by Vpx.
The results described above indicate that PIM kinase–mediated
phosphorylation of lentiviral Vpx regulates its function in down-
regulating SAMHD1. We next examined the effect of PIM kinase
inhibition on lentiviral replication. To this end, Monomac6
macrophage were stably transduced with shRNAs targeting PIM1
and PIM3, and then infected with HIV-2-Luc (Fig. 5a). Simul-
taneous knockdown of PIM1 and PIM3 significantly blocked viral
infection through the prevention of SAMHD1 degradation
(Fig. 5b, c), whereas depletion of either PDK1 or PIM2 had no
effect on viral infectivity (Supplementary Fig. 10). Notably, the
infectivity of the Vpx-S13A virus was comparable to that of the
wild-type virus, albeit at a relatively low level, in PIM1/3-depleted
macrophages (Fig. 5b, c). Moreover, when PIM1 and PIM3
kinases were depleted in producer cells, viral infectivity was not
significantly affected (Fig. 5d–f). These results together indicate
that PIM1 and PIM3 have a profound effect upon Vpx Ser13 in
target cells, but not in producer cells, implying their action on the
early stages of viral life cycle.
Currently, several potential pharmacological inhibitors of PIM
kinase are under development, and a few are in clinical trials in
anti-cancer treatments. To determine whether PIM kinase
inhibitors could block HIV-2 infection, we treated primary
human monocyte–derived macrophages with the pan-PIM kinase
inhibitor AZD120820 prior to HIV-2-Luc infection (Fig. 6a). As
expected, this compound inhibited HIV-2 infection in a dose-
dependent manner while preventing SAMHD1 degradation
(Fig. 6b, c). However, this effect was not observed in cells
infected with the Vpx-S13A virus, which has low infectivity in
nature (Fig. 6b, c). Moreover, we found that the inhibitory effects
of AZD1208 were significantly attenuated when SAMHD1 was
depleted in target macrophages (Fig. 6d, e). AZD1208 was not
cytotoxic at effective concentrations (~1 µM), but interestingly,
this drug exhibited a greater cytotoxic effect in Monomac6-







































































































































































































































Fig. 3 Low infectivity of HIV-2 bearing Vpx-S13A in myeloid cells. a–d Single-cycle HIV-2 infection assays in various human macrophages. Schematic
representation of the experimental design (a). Briefly, monocytic cells were differentiated into macrophages by PMA or M-CSF and then infected with the
indicated HIV-2 encoding luciferase (Luc) reporter gene. Forty-eight hours after infection, intracellular luciferase activity was measured for Monomac6
(MM6) (b), U937 (c) and primary monocyte-derived macrophage (d). Endogenous SAMHD1 expression in infected cells is also shown. Bar charts below
the blot indicate the ratio of SAMHD1 over Tubulin, as determined by densitometry. e, f Multi-cycle HIV-2 replication kinetics in THP1-derived
macrophages. Schematic representation of the experimental procedure (e). Cells were infected with wild-type HIV-2GL-AN and its Vpx-S13A, Q76A, and
Vpx-deficient mutants. RT activity of each supernatant was measured at the indicated time points (f). g SAMHD1 expression in the indicated HIV-
2–infected THP1-macrophages, 12 days after infection. Bar chart below the blot indicates the ratio of SAMHD1 over Tubulin, as determined by
densitometry.All graphs are presented as a mean ± s.d. (n= 3). *P < 0.05; **P < 0.01; ns, not significant, two-tailed unpaired t-test. Source data are provided
as a Source Data file
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Fig. 11). Another PIM inhibitor, SGI177621, also exhibited
inhibitory effects on HIV-2 infection similar to those of
AZD1208 (Fig. 6f). Together, our data clearly indicate that
selective PIM kinase inhibitors potentiate the antiviral activity of
SAMHD1 by suppressing Vpx phosphorylation and function.
PIM kinase inhibitors block lentiviral replication. To clarify the
effect of PIM kinase inhibitors on multi-cycle viral replication in
primary cells, we treated human primary macrophages with HIV-
2 in the presence or absence of PIM kinase inhibitors for 7 days,
and then calculated the yield of progeny virus (Fig. 7a). Notably,
our results demonstrated that treatment with only 1 µM of either
AZD1208 or SGI1776 could block the HIV-2 replication (Fig. 7b).
Notably, these compounds exerted no observable effect on the
replication of HIV-1 that does not encode Vpx (Fig. 7b).
The results described above indicated that the Ser13 residue of
Vpx is highly conserved within the HIV-2/SIVmac/SIVsmm
lineage (Fig. 2c); consistent with this, SIVmac Vpx was also
phosphorylated by PIM3 (Fig. 2f). Accordingly, we investigated
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ex vivo. To this end, we prepared virally infected mononuclear
cell mixtures from the lymph nodes of SIVmac-infected rhesus
macaques. Prior to brief stimulation, only macrophages adhered
to the bottoms of dishes were recovered. The cells were then
treated with PIM kinase inhibitors for 7 days (Fig. 7c). Notably,
treatment with either AZD1208 or SGI1776 could significantly
block viral replication (Fig. 7d). Taken together, these results
confirm that PIM kinases are potent therapeutic targets for
lentiviral infection.
Discussion
In recent years, a great deal of effort has been made to discover a
new mode of virus–host protein interactions to understand the
molecular basis underlying virus infection1,2. During viral
replication, viruses take advantage of cellular enzymes to optimize
viral protein function in infected cells. Phosphorylation of viral
proteins by host kinases is critical for efficient viral replication
and pathogenesis22. Several viruses encode their own protein
kinases for these modifications (e.g., herpes simplex virus-
thymidine kinase), but lentiviruses have no such virally encoded
kinase. Instead, these viruses have evolved to hijack host protein
kinases for viral protein phosphorylation in order to ensure
efficient viral replication. Indeed, a previous study predicted a
large number of as-yet-unidentified phosphorylation sites on viral
proteins23. Identification of host kinases involved in viral protein
phosphorylation and their functional modification could facilitate
the development of new antiviral strategies24. In our current
study, by screening for human protein kinases that target
Fig. 4 Vpx Ser13 phosphorylation strengthens the Vpx–SAMHD1 interaction. a Primary structure of Vpx, showing the SAMHD1-binding (red) and DCAF1-
binding (green) motifs19. Arrow indicates the residue of phospho-Ser13. b Molecular dynamics simulations of Vpx (blue) coupled with peptides derived
from SAMHD1 (red) and DCAF1 (gray) in the absence (left) or presence (right) of Vpx Ser13 phosphorylation. c Expanded view of a predicted hydrogen
bond between phospho-Vpx and SAMHD1 (shown in an orange line). d, e NanoBRET assays of HEK293 cells expressing NanoLuc-conjugated Vpx and
either SAMHD1 (d) or DCAF1 (e) fused with HaloTag. Forty-eight hours after transfection, intracellular NanoBRET signals were calculated. All graphs are
presented as a mean ± s.d. (n= 3). ***P < 0.001; ns, not significant, two-tailed unpaired t-test. f–h Vpx-S13A binds SAMHD1 to a lesser extent than wild-
type Vpx. HEK293 cells expressing HA-SAMHD1 (f) or HA-DCAF1 (g) and either FLAG-Vpx WT or S13A were lysed; and the resultant lysates were
immunoprecipitated with anti-FLAG (f, g) or anti-HA antibodies (h); the precipitants were analyzed by immunoblotting. The numerical values below the
blots show the signal intensities of the indicated precipitants, as determined by densitometry. i Vpx-S13A is less capable of poly-ubiquitinating SAMHD1
than wild-type Vpx. HEK293 cells were cotransfected with plasmids encoding HA-SAMHD1, FLAG-Vpx (WT or S13A), and Myc-ubiquitin. The cells were
then treated with MG132 for 18 h and harvested. Cell lysates were immunoprecipitated with anti-HA antibody, and the Vpx-induced ubiquitination of



















































































































































Fig. 5 Depletion of PIM kinases attenuates anti-SAMHD1 activity of Vpx. a–c Knockdown of PIM1 and PIM3 results in reduced viral replication. Schematic
representation of the experimental system (a). Monomac6 (MM6) cells were stably transduced with shRNAs targeting PIM1 and PIM3. Cells were then
differentiated into macrophages and infected with HIV-2 luciferase (Luc) reporter virus. Forty-eight hours later, the cells were harvested and subjected to
luciferase assay (b) and immunoblotting (c) to measure HIV-2 infectivity and SAMHD1 expression, respectively. d–f Knockdown of PIM1 and PIM3 in
producer cells does not affect late stage of virus replication cycle. Schematic representation of the experimental procedure (d). HEK293 cells were treated
with either control or PIM-targeted siRNA for 24 h before transfection with an HIV-2 molecular clone. After 48 h, virus-containing culture supernatants
were harvested. Equal amounts of HIV-2 were then used to infect Monomac6-derived macrophages. Forty-eight hours later, cells were subjected to
luciferase assay to measure HIV-2 infectivity (e). Expressions of PIM1 and PIM3 in HEK293 producer cells are also shown (f). All graphs are presented as a
mean ± s.d. (n= 3). ***P < 0.001; ns, not significant, two-tailed unpaired t-test. Source data are provided as a Source Data file
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lentiviral Vpx, we identified PIM family kinases (PIM1 and
PIM3) as previously unrecognized positive regulators of lentiviral
replication that enable viral evasion from SAMHD1-mediated
restriction. Our current data indicate that these PIM family
kinases target a highly conserved residue of Vpx, Ser13, and that
this phosphorylation stabilizes the binding of Vpx to SAMHD1,
resulting in efficient SAMHD1 degradation and viral replication
(Fig. 7e). These findings demonstrate a previously undescribed
paradigm in virus-host interaction ensuring the efficient lentiviral
replication despite the existence of host restriction system.
The antiviral activity of SAMHD1 is limited to non-dividing
cells such as macrophages and resting T cells, partially due to
its role in limiting the supply of cytoplasmic dNTP. To
overcome this potent antiviral factor, Vpx expropriates the
host CRL4 E3 ubiquitin ligase complex and induces degradation
of SAMHD15,6,9. Although the mechanistic action of Vpx on
SAMHD1 is well characterized, it is largely unknown how the
antagonizing activity of Vpx is regulated. Previous studies have
reported that host kinases FYN and ERK2 can phosphorylate
tyrosine residues (Tyr66, 69, 71) of Vpx, thereby regulating its
nuclear export and viral infectivity14,15. However, no previous
study had reported evidence that Vpx phosphorylation is func-
tionally relevant to viral escape from SAMHD1-mediated
restriction. Our current results strongly suggest that the PIM
family kinases PIM1 and PIM3 target a highly conserved residue
of Vpx, Ser13, and that this phosphorylation affects the binding of
Vpx to SAMHD1, and thus its activity. Moreover, we showed
here that PIM kinase inhibitors selectively block lentiviral
replication by preventing Vpx-mediated SAMHD1 proteolysis.
Notably, the pan-PIM kinase inhibitor AZD1208 has undergone
clinical trials for hematological cancers25. Because PIM kinase
promotes replication of Hepatitis C virus26, AZD1208 might
provide new therapeutic options against a series of virus infection.
PIM family kinases were originally identified as a target for
proviral activation in T-cell lymphomas induced by murine leu-
kemia virus27. Accordingly, PIM kinases are highly expressed in
patients with lymphoma, leukemia, and prostate cancers28,29.
Because elevated expression of PIM kinases prevents apoptosis,
thereby increasing oncogenic activity, PIM kinases have been
suggested as attractive drug targets in cancer. We found that
AZD1208 has relatively high cytotoxicity in Monomac6-derived
macrophages (Supplementary Fig. 11), presumably because this
cell line was derived from human monoblastic leukemia, a known
therapeutic target of AZD120820,30. Importantly, however, this
drug is much less toxic in primary macrophages, warranting its
use in antiviral therapy. Although PIM family kinases are highly
homologous to one another and share similar substrate specifi-
city31, our results showed that both PIM1 and PIM3 could
phosphorylate Vpx Ser13. At present, we cannot exclude the
possibility that PIM2 phosphorylates other residue(s) of Vpx.
Additionally, our in vitro kinase assays revealed that PIM1 may
more selectively phosphorylate Ser13, whereas PIM3 broadly
phosphorylates other residues in Vpx as well (Figs. 1d and 2d).
Detailed experiments should be needed to reveal the substrate
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Fig. 6 PIM kinase inhibition prevents Vpx-mediated SAMHD1 degradation. a–c PIM kinase inhibitors block HIV-2 infection in primary human
monocyte–derived macrophages. Schematic representation of the experimental design (a). Primary monocytes were differentiated into macrophages and
infected with HIV-2 reporter virus carrying wild-type Vpx or its S13A mutants. A pan-PIM kinase inhibitor AZD1208 was added 4 h before infection. Forty-
eight hours post-infection, cells were harvested and subjected to luciferase assay (b) and immunoblotting (c) to measure HIV-2 infectivity and SAMHD1
expression, respectively. d–f The effect of PIM kinase inhibitors is SAMHD1-dependent. Schematic representation of the experimental procedure (d).
Monomac6 (MM6) cells stably expressing shRNAs targeting SAMHD1 were differentiated into macrophages and infected with wild-type HIV-2 reporter
virus. AZD1208 (e) or SGI1776 (f) was added 4 h before infection. Forty-eight hours post-infection, cells were harvested and subjected to luciferase assay
to measure HIV-2 infectivity. All graphs are presented as a mean ± s.d. (n= 3). **P < 0.01; ***P < 0.001; ns, not significant, two-tailed unpaired t-test.
Source data are provided as a Source Data file
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The amino acid residue Ser13 in Vpx is highly conserved
among clinically isolated HIV-2 strains, whose Vpx proteins are
capable of degrading SAMHD1. A mutagenesis study revealed
that alanine substitution of Vpx Ser13 results in lower viral
infectivity than the wild-type virus, even though the mutant
protein is as stable as WT Vpx32. Our molecular dynamics
simulation and subsequent biomolecular analyses clearly
demonstrated that Vpx Ser13 phosphorylation could enhance
SAMHD1 binding, presumably by forming an additional hydro-
gen bond between phospho-Vpx and SAMHD1. Consequently,
phosphorylation of Vpx enhances ubiquitin-mediated proteolysis
of SAMHD1. Consistent with this, phosphorylation of the con-
served amino acid of HIV proteins seems to be associated with
viral escape from host antiviral immunity. For example, Vif-
Ser144 and Vpu-Ser52,56 are highly conserved phospho-acceptor
sites whose phosphorylation regulates antagonizing activity
against the restriction factors APOBEC3G and Tetherin,
respectively33,34. These post-translational modifications thus
represent attractive targets for the development of novel anti-HIV
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Fig. 7 PIM kinase inhibitors block lentiviral replication in primary macrophages. a, b HIV-2 replication kinetics in primary monocyte–derived macrophages.
Schematic representation of the experimental design (a). Cells were infected with wild-type HIV-2GL-AN or HIV-189.6 in the presence of AZD1208 or
SGI1776 (1 µM). A HIV protease inhibitor darunavir (DRV, 1 µM) was used as a control. Replication kinetics were monitored by ELISA of extracellular viral
p27 or p24 capsid antigens (b). c, d PIM kinase inhibitors can block SIV replication ex vivo. Schematic representation of the experimental procedure (c).
Cells derived from a lymph node of an SIV-infected macaque monkey were seeded onto dishes. After suspension cells were removed, the remaining cells
were stimulated with TNF-α (50 ngml−1) for 24 h, and then treated with either AZD1208, SGI1776, or DRV (1 µM) for 7 days. The levels of progeny virions
in culture supernatants were determined by SIV p27 ELISA (d). e Schematic diagram illustrating the proposed role of PIM kinases in lentiviral infection. In
infected macrophages, Vpx targets SAMHD1 for ubiquitination and proteasomal degradation by forming CRL4 E3 ubiquitin ligase complex. PIM family
kinases (PIM1 and PIM3) target a highly conserved residue of Vpx, Ser13, and that this phosphorylation stabilizes the binding of Vpx to SAMHD1, resulting
in efficient SAMHD1 degradation and viral replication. All graphs are presented as a mean ± s.d. (n= 3). *P < 0.05; **P < 0.01, two-tailed unpaired t-test.
Source data are provided as a Source Data file
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Methods
AlphaScreen-based protein–protein interaction assays. For the initial screen,
we used a total of 412 complementary DNA library encoding human protein
kinases35,36. DNA templates containing a biotin-ligating sequence were amplified
by split-PCR with cDNAs and corresponding primers, and then used with the
GenDecoder protein production system (CellFree Science)37–39. For synthesis of
Vpx protein, vpx genes derived from the pGL-AN proviral plasmid40 were
generated by split-PCR and used as DNA templates. FLAG-tagged Vpx proteins
were mixed with biotinylated kinases in 15 µl of reaction buffer (20 mM Tris–HCl
pH 7.6, 5 mM MgCl2, 1 mM DTT) in 384-well OptiPlates (PerkinElmer) and
incubated at 26 °C for 1 h. Each sample was then mixed with AlphaScreen buffer
containing anti-immunoglobulin G (protein A) acceptor beads and streptavidin-
coated donor beads (0.1 µl each; PerkinElmer) and the anti-FLAG M2 antibody
(5 µg ml−1; Sigma-Aldrich), and further incubated at 26 °C. One hour later,
AlphaScreen signals from the mixture were detected on an EnVision device
(PerkinElmer) using the AlphaScreen signal detection program.
NanoBRET-based protein–protein interaction assays. Expression vectors
encoding N-terminally HaloTag-conjugated host proteins (kinases, DCAF1 and
SAMHD1) were prepared by Kazusa Genome Technologies (Chiba, Japan) and
purchased from Promega. For NanoBRET analysis41, HEK293 cells in white 96-
well white plates were transfected with vectors encoding HaloTag-fused protein
(100 ng) and NanoLuc-fused Vpx (1 ng). At 48 h post-transfection, NanoBRET
activity was measured using the NanoBRET Nano-Glo Detection System
(Promega).
In vitro kinase assays. Recombinant Vpx proteins were incubated with GST-
tagged or His-tagged PIM kinases for 1 h at 37 °C in reaction buffer (20 mM
Tris–HCl pH 7.5, 1 mM EDTA, 1 mM DTT, 150 mM NaCl, 5 mM MgCl2, 0.05%
Tween-20, 100 μM ATP, and 2 μCi [γ-32P] ATP). The reaction mixture was sub-
jected to electrophoresis on 10% SDS polyacrylamide gels, and the proteins were
visualized on a BAS2500 image analyzer (Fujifilm, Japan). Alternatively, the pro-
teins were subjected to immunoblotting using a phospho-specific polyclonal
antibody against Vpx phosphorylated at Ser13 (produced by Scrum Inc., Japan).
Liquid chromatography tandem-mass spectrometry analysis. HEK293 cells
expressing FLAG-Vpx and HA-PIM3, grown in 10-cm dishes, were immuno-
precipitated with EZview Red FLAG M2 Affinity Gel (Sigma-Aldrich), and
bound proteins were subjected to liquid chromatography tandem-mass spec-
trometry analysis. Bead-bound proteins were denatured with 8 M urea and
50 mM ammonium bicarbonate, and subsequently digested with trypsin for
16 h at 37 °C after reduction and alkylation. The resulting peptides were
desalted using C18 Stage Tips42 filled with C18 and SDB Empore disc mem-
branes (3 M) and evaporated in a vacuum concentrator. Phosphopeptides were
then enriched using Titansphere TiO2 bulk beads (GL Sciences, Tokyo, Japan).
After re-desalting with C18 stage Tips, phosphopeptides were analyzed on an
LTQ Orbitrap Velos (Thermo Fisher Scientific) equipped with an UltiMate
3000 LC system (Thermo Fisher Scientific). Protein identification was per-
formed using the MASCOT search engine, version 2.5.1 (Matrix Science) with
the Swiss-Prot database (July 2014) with the following parameters: enzyme,
trypsin; peptide mass tolerance, ± 5 ppm; fragment mass tolerance, ± 0.5 Da;
maximum missed cleavage sites, 2; variable modifications: carbamidomethy-
lation of cysteine, phosphorylation of serine or threonine, oxidation of
methionine. We used a significance threshold of p < 0.05 as a cutoff to export
results from the analysis by MASCOT. In addition, phosphopeptides that
yielded a peptide ion score > 30 were considered positive identifications.
Cells and virus preparation. HEK293 cells (ATCC, #CRL-1573) were maintained in
DMEM supplemented with 10% fetal bovine serum (FBS). THP-1 (JCRB, #0112) and
U937 (JCRB, #9021) were cultured in RPMI (Wako) supplemented with 10% FBS.
Monomac6 cells, a human monocyte-derived cell line exhibiting a mature monocyte
phenotype30, were kindly provided by Dr. Akinori Takaoka (Hokkaido University)
and maintained in RPMI containing 10% FBS, 1mM sodium pyruvate (Wako), 100
µgml−1 insulin (Sigma-Aldrich), and 1% non-essential amino acids (Thermo Fisher
Scientific). For differentiation of U937 and Monomac6 cells to macrophages, the cells
were differentiated for 24 h with 100 ngml−1 of phorbol 12-myristate 13-acetate
(PMA, Sigma-Aldrich). Human CD14+ monocytes, purchased from PromoCell (#C-
12909), were differentiated in RPMI supplemented with 10% FBS and 1000U ml−1
M-CSF (Wako) for 8 days. For transient knockdown, cells were transfected with gene-
specific siRNA (Qiagen) using Lipofectamine RNAiMAX Transfection Reagent
(Thermo Fisher Scientific). To generate PIM kinases- or SAMHD1-depleted Mono-
mac6 cells, cells were transduced with lentiviral particles carrying gene-specific
shRNA (Santa Cruz Biotechnology, catalog numbers #sc-36225-V, #sc-61353-V, and
#sc-76442-V), and then selected with 1 µgml−1 puromycin (InvivoGen). HIV stocks
were produced by transient transfection of HEK293 cells (10 cm dishes) with 10 µg of
the molecular clone p89.6 (for HIV-189.6)43 or pGL-AN (for HIV-2GL-AN)40. Vpx
mutants were generated using PCR-based molecular cloning procedures. HIV-2-Luc
reporter viruses were produced by co-transfection of HEK293 cells (10 cm dishes)
with 3 µg of VSV-G expression vector and either 10 µg of pGL-ANΔEnv-Luc or pGL-
STΔEnv-Luc18. After 48 h, culture supernatants containing virus were collected and
filtered through a 0.45-µm Millex-HV filter (Millipore).
Immunoblotting and immunoprecipitation. For immunoprecipitation analysis44–46,
HEK293 cells in six-well plates were transfected with vectors encoding FLAG-Vpx
(500 ng) and HA-tagged protein expression plasmids (500 ng). At 48 h post-transfec-
tion, cells were lysed with HBST buffer (10mM HEPES pH 7.4, 150mM NaCl, 0.5%
Triton-X-100) containing protease inhibitor Complete mini (Roche Diagnostics). Cell
lysates were immunoprecipitated with anti-HA or FLAG EZview Red Affinity Gel
(Sigma-Aldrich) for 16 h, and bound proteins were analyzed by immunoblotting as
follows. Samples in SDS loading buffer were loaded onto 10% polyacrylamide gels,
electrophoresed, and blotted onto PVDF membranes (Millipore). Membranes were
probed with primary antibodies and horseradish peroxidase-conjugated secondary
antibodies (GE Healthcare). Detected proteins were visualized using a FluorChem
digital imaging system (Alpha Innotech). Band analysis was performed with ImageJ
software (NIH). For SAMHD1 ubiquitination assays, HEK293 cells in six-well plates
were transfected with vectors encoding FLAG-Vpx (500 ng), HA-SAMHD1 (1 µg), and
Myc-ubiquitin (1 µg). Cells were treated with 2 µM MG132 (Sigma-Aldrich) for 18 h
before being harvested. The antibodies used in this study are listed in Supplementary
Table 1. Full images of all immunoblots are provided in Source Data file.
Single-cycle HIV-2 infection assay. Macrophages in 24-well plates were infected
with VSV-G-pseudotyped HIV-2-Luc reporter viruses (2 ng of Gag p27 antigen).
Forty-eight hours later, cells were subjected to immunoblot analysis or luciferase
assay for calculating viral infectivity using Bright-Glo Luciferase Assay System
(Promega). For experiments with PIM inhibitors, cells were treated with SGI1776
(Merck Millipore) or AZD1208 (MedChem Express) 4 h before infection.
Multi-cycle viral replication assay. Differentiated THP-1 cells in 24-well plates
were infected with equal amounts of viruses (105 reverse transcriptase units), and
replication kinetics were calculated by reverse transcriptase activity of virus-
containing culture supernatants18. For the experiment with PIM kinase inhibitors,
macrophages in 24-well plates were infected with replication-competent HIV-
2GL-AN (5 ng of Gag p27 antigen) or HIV-189.6 (20 ng of Gag p24 antigen) using the
ViroMag Transfection Reagent (OZ Biosciences). Replication kinetics were calcu-
lated based on the level of extracellular viral capsid antigens using the SIV p27 or
HIV p24 ELISA kit (ZeptoMetrix). For the experiment with SIV-infected cells, we
used frozen cells derived from the lymph node of a macaque monkey infected with
SIVmac251. The animal study was conducted under the guidelines provided by
both Primate Research Institute (PRI) and Institute for Frontier Life and Medical
Sciences (INFRONT), Kyoto University after the approval of Animal Welfare
and Care Committee in the University. Research permission numbers were
2016–081 and 2017–116 for PRI and B15–3 and B15-3-2 for INFRONT, respec-
tively. After removal of suspension cells, the remaining cells were stimulated with
TNF-α (50 ng ml−1) for 24 h, and then treated with either SGI1776, AZD1208,
or darunavir (1 µM) for 7 days. The levels of progeny virions in the culture
supernatants were determined using the SIV p27 ELISA kit (ZeptoMetrix).
Molecular dynamics (MD) simulation. The X-ray crystal structure of SAMHD1-
Vpx-DCAF1 (Protein Data Bank code: 4CC9) was used as the template structure.
On the basis of the predicted structural model of SAMHD1 with wild-type Vpx,
three-dimensional structures of SAMHD1 with either unphosphorylated or
phosphorylated Vpx were constructed using Molecular Builder in the Molecular
Operating Environment software. MD simulations were performed by the pmemd
module in the Amber 11 program package47 with the AMBER ff99SB-ILDN force
field48 and the TIP3P water model for simulations of aqueous solutions49. A non-
bonded cutoff of 10 Å was used. Bond lengths involving hydrogen were constrained
with SHAKE, a constraint algorithm to satisfy Newtonian motion50, and the time
step for all MD simulations was set to 2 fs. After heating calculations for 20 ps until
310 K using the NVT ensemble, simulations were executed using the NPT
ensemble at 1 atm, at 310 K, and in 150 mM NaCl for 100 ns.
Statistical analysis. All bar graphs present means and s.d. The statistical
significance of differences between two groups was evaluated by two-tailed
unpaired t-test in the Prism 6 software (GraphPad). A p value > 0.05 was
considered statistically significant.
Data availability
The MS raw data have been deposited to the jPOSTrepo (Japan ProteOme STandard
Repository) with the dataset identifier PXD013154. The source data underlying Figs. 1d,
2d–f, 3b-g, 4d-i, 5b–f, 6b–f, 7b and d, and Supplementary Figs. 4a, b, 5, 6a,b, 8a, b, 9, 10b,
c and 11 are provided as a Source Data file.
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